ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ACRV Acrivon Therapeutics Inc

7,25
-0,47 (-6,09%)
15 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Acrivon Therapeutics Inc ACRV NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,47 -6,09% 7,25 01:00:01
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
7,65 7,10 7,73 7,25 7,72
mais cotações »

Notícias Recentes

Data Hora Fonte Título
29/05/202409:00GLOBEAcrivon Therapeutics to Present at the Jefferies Global..
14/05/202409:00GLOBEAcrivon Therapeutics Reports First Quarter 2024 Financial..
24/04/202417:01GLOBEAcrivon Therapeutics Reports Initial Positive Clinical Data..
16/04/202421:01GLOBEAcrivon Therapeutics to Host Corporate R&D Event..
10/04/202409:00GLOBEAcrivon Therapeutics Presents Data at AACR Annual Meeting..
09/04/202408:00GLOBEAcrivon Therapeutics Announces $130 Million Private..
28/03/202409:00GLOBEAcrivon Therapeutics Reports Fourth Quarter and Full Year..
05/03/202418:30GLOBEAcrivon Therapeutics to Present Data at AACR Annual Meeting..
04/03/202410:00GLOBEAcrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA,..
27/02/202410:00GLOBEAcrivon Therapeutics to Participate in a Panel Discussion at..
08/02/202410:00GLOBEAcrivon Therapeutics Appoints Seasoned Industry Executive..
06/02/202410:00GLOBEAcrivon Therapeutics to Present at the Oppenheimer 34th..
12/01/202418:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
04/01/202410:00GLOBEAcrivon Therapeutics to Present at the 42nd Annual J.P...
28/11/202310:58DJNAcrivon Therapeutics Gets FDA's Breakthrough Designation for..
28/11/202310:00GLOBEAcrivon Therapeutics Announces FDA has Granted Breakthrough..
21/11/202310:00GLOBEAcrivon Therapeutics to Present at the Piper Sandler Annual..
09/11/202310:01GLOBEAcrivon Therapeutics Reports Third Quarter 2023 Financial..
16/10/202309:00GLOBEAcrivon Therapeutics Presents Data Demonstrating..
28/09/202317:05GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
19/09/202317:32GLOBEAcrivon Therapeutics to Highlight its ACR-368 OncoSignature..
05/09/202317:05GLOBEAcrivon Therapeutics Announces ACR-2316, a Novel Dual WEE1..
30/08/202309:00GLOBEAcrivon Therapeutics to Participate in Two Investor..
17/08/202317:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
11/08/202308:00GLOBEAcrivon Therapeutics Reports Second Quarter 2023 Financial..
20/07/202309:00GLOBEAcrivon Therapeutics Announces the Appointment of Adam Levy,..
22/06/202317:00GLOBEAcrivon Therapeutics Announces the Appointment of Seasoned..